Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

v2.4.0.8
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (USD $)
 6 Months Ended
Jun. 30, 2013
Jun. 30, 2012
OPERATING ACTIVITIES    
Net Income (loss) $ 334,399 $ (29,248)
Adjustments to reconcile net income (loss) to net cash flows used in operating activities:    
Amortization of intangible assets 342,500 0
Change in operating assets and liabilities:    
Prepaid expense 0 1,750
Prepaid inventory 285,039 0
Accounts receivable (1,165,058) 0
Inventory (1,832,346) 0
Accounts payable and accrued expenses 47,657 9,143
Net cash flows used in operating activities (1,987,809) (18,355)
INVESTING ACTIVITIES    
Cash received on acquisition 50,775  
Purchase of property and equipment (17,027)  
Cash paid on PhytoSPHERE agreement (750,000)  
Investment in Kanalife (500,000)  
Net cash flows used in investing activities (1,216,252)  
FINANCING ACTIVITIES    
Proceeds from loan from Roen Ventures 3,280,500 0
Proceeds from loan from related party 0 17,300
Repayment of loan from related party (200) 0
Net cash flows from financing activities 3,280,300 17,300
Net increase (decrease) in cash 76,239 (1,055)
Cash, beginning of period 431 1,168
Cash, end of period 76,670 113
NON CASH TRANSACTION:    
Accounts receivable assumed from acquisitions 396,438  
Inventory assumed from acquisitions 345,477  
Prepaid inventory 1,260,510  
Property and equipment assumed from acquisitions 1,288  
Intangible assets 4,110,000  
Goodwill 1,855,512  
Amount due from PhytoSPHERE agreement (4,963,906)  
Common Shares issued for PhytoSPHERE Transaction $ (2,306,094)